BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2

被引:365
作者
Lee, MH
Kwon, TG
Park, HS
Wozney, JM
Ryoo, HM [1 ]
机构
[1] Kyungpook Natl Univ, Sch Dent, Dept Biochem, Taegu 700422, South Korea
[2] Kyungpook Natl Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Taegu 700422, South Korea
[3] Kyungpook Natl Univ, Sch Dent, Dept Orthodont, Taegu 700422, South Korea
[4] Genet Inst Inc, Cambridge, MA 02140 USA
[5] Kyungpook Natl Univ, Skeletal Dis Genome Res Ctr, Taegu 700422, South Korea
关键词
Osterix; BMP-2; Dlx5; Runx2; osteoblast;
D O I
10.1016/j.bbrc.2003.08.058
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BMP-2 stimulates the expression of three osteogenic master transcription factors: Runx2, D1x5, and Osterix (Osx). However, the hierarchical regulatory relationships among them are not yet clearly understood. Osx was commonly stimulated in osteogenic and non-osteogenic cells in response to BMP-signaling, as D1x5 was in our previous report. A cycloheximide experiment indicated that Osx expression by BMP-2 requires new protein synthesis. Even if Osx has been suggested as a downstream target of Runx2, the results of this study indicated that Osx expression was still induced by BMP-2 treatment in Runx2 null cells, but not induced by Runx2 overexpression in myogenic C2C12 cells. Instead, Osx expression by BMP-2 was completely abrogated by the antisense blocking of D1x5. Depending upon the coincident expression pattern of Osx and D1x5, and the blocking of Osx expression by the antisense D1x5, BMP-2-induced Osx expression is mainly mediated not by Runx2, but by D1x5. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:689 / 694
页数:6
相关论文
共 27 条
[1]  
Acampora D, 1999, DEVELOPMENT, V126, P3795
[2]   Constitutively active BMP type I receptors transduce BMP-2 signals without the ligand in C2C12 myoblasts [J].
Akiyama, S ;
Katagiri, T ;
Namiki, M ;
Yamaji, N ;
Yamamoto, N ;
Miyama, K ;
Shibuya, H ;
Ueno, N ;
Wozney, JM ;
Suda, T .
EXPERIMENTAL CELL RESEARCH, 1997, 235 (02) :362-369
[3]   Advances in the osteoblast lineage [J].
Aubin, JE .
BIOCHEMISTRY AND CELL BIOLOGY, 1998, 76 (06) :899-910
[4]   Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation [J].
Ducy, P ;
Zhang, R ;
Geoffroy, V ;
Ridall, AL ;
Karsenty, G .
CELL, 1997, 89 (05) :747-754
[5]   TGF-beta signalling from cell membrane to nucleus through SMAD proteins [J].
Heldin, CH ;
Miyazono, K ;
tenDijke, P .
NATURE, 1997, 390 (6659) :465-471
[6]   BONE MORPHOGENETIC PROTEIN-2 CONVERTS THE DIFFERENTIATION PATHWAY OF C2C12 MYOBLASTS INTO THE OSTEOBLAST LINEAGE [J].
KATAGIRI, T ;
YAMAGUCHI, A ;
KOMAKI, M ;
ABE, E ;
TAKAHASHI, N ;
IKEDA, T ;
ROSEN, V ;
WOZNEY, JM ;
FUJISAWASEHARA, A ;
SUDA, T .
JOURNAL OF CELL BIOLOGY, 1994, 127 (06) :1755-1766
[7]   The protein kinase c pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2 [J].
Kim, HJ ;
Kim, JH ;
Bae, SC ;
Choi, JY ;
Kim, HJ ;
Ryoo, HM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (01) :319-326
[8]   Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts [J].
Komori, T ;
Yagi, H ;
Nomura, S ;
Yamaguchi, A ;
Sasaki, K ;
Deguchi, K ;
Shimizu, Y ;
Bronson, RT ;
Gao, YH ;
Inada, M ;
Sato, M ;
Okamoto, R ;
Kitamura, Y ;
Yoshiki, S ;
Kishimoto, T .
CELL, 1997, 89 (05) :755-764
[9]   Runx2 is a common target of transforming growth factor β1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12 [J].
Lee, KS ;
Kim, HJ ;
Li, QL ;
Chi, XZ ;
Ueta, C ;
Komori, T ;
Wozney, JM ;
Kim, EG ;
Choi, JY ;
Ryoo, HM ;
Bae, SC .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (23) :8783-8792
[10]  
Lee MH, 1999, J CELL BIOCHEM, V73, P114, DOI 10.1002/(SICI)1097-4644(19990401)73:1<114::AID-JCB13>3.3.CO